Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / @xirurgi_2025 / @xirurgi_2025 - 394 - файл

.pdf
Скачиваний:
0
Добавлен:
29.08.2026
Размер:
45 Мб
Скачать
122 ATYPICAL CAUSES OF LEG ULCERATION
https://t.me/medicina_free
of associated vascular disease and the results of a vascular assessment. Ulcer appearance and location can be indicative of the underlying inammatory disorder as described earlier, and of the potential impact of pressure and friction. All of these factors can be combined with the results of a skin biopsy if one is performed to make a diagnosis.
Intervention
A multidisciplinary approach involving the rheumatologist is important to successfully manage rheumatoid ulcers. Due to the link between the systemic treatments for RA and wound healing, advice from the rheumatologist with regard to the therapies being used to manage RA is paramount. Reduction of the dose of immunosuppressant medication or temporary discontinuation until wound healing has been achieved may be advocated in some cases (Bootan 2013), or suggestions around switching to a dierent type of DMARD or anti­TNF treatment may be made. Such discussions will assist in balancing control of the underlying RA, prevention of disease progression and minimising the impact of RA symptoms on a patient’s quality of life with maximising the wound healing potential of associated ulceration.
Podiatrist and/or orthotist input can also be useful to manage and ooad any foot deformities contributing to existing ulceration, and also for prevention of further wounds. Input from a physiothera­pist and occupational therapist can help with improving mobility, functional activity and education on protecting the joints (Firth2011).
Management of the wound bed and exudate levels using appropriate primary and secondary dressings is important– gentle autolytic debridement of sloughy tissue is recommended as opposed to less conservative methods to reduce the risk of infection in immunocompromised patients. Good skincare using cleansing and emollients will help to maintain skin integrity, particularly if the skin is thin and fragile as a consequence of corticosteroid use. This should also be a consideration when choosing appropriate dressings. If using an adhesive dressing, gentle silicone dressings are advised, and a silicone medical adhesive remover can also be useful to reduce the risk of skin trauma and any dressing­Topical antimicrobial dressings may be required if the wound is displaying any signs of local infection.
related pain (Young 2019).
Atypical Causes of Leg Ulceration 123
https://t.me/medicina_free
Compression therapy following vascular assessment is a useful adjunct when managing rheumatoid ulcers to address any venous insuciency and dependent oedema once signicant arterial disease has been ruled out. While peripheral neuropathy is not an absolute contraindication to compression therapy, clinicians should be mindful of the loss of protective sensation experienced by these patients. Patients may not detect any pain or discomfort associated with compression therapy that is too tight or that may have inadvertently caused trauma to the skin from pressure damage (Dissemond et al. 2016). It is recommended that compression therapy instigated in patients with peripheral neuropathy is reviewed more frequently for signs of complications from compression, particularly in the early stages after commencing treatment, and a reduced level of compression therapy (see Chapter 8) may be indicated where there are concerns over the patient’s ability to detect increasing pain or complications (Australian Wound Management Association and New Zealand Wound Care Society 2011; Todhunter 2019). Compression bandaging may be the most appropriate option for therapy in view of the likelihood of reduced dexterity and limb deformity making the application of compression hosiery or adjustable compression wraps dicult. Also, the requirement for adequate padding over bony prominences, nodules and fragile areas susceptible to high pressure may be more easily achieved with the use of sub­compression bandages.
bandage wadding underneath
Systemic Scleroderma
Systemic scleroderma or sclerosis is a rare autoimmune disorder that results in damage to connective tissue to the skin and internal organs, and functional and structural abnormalities of small blood vessels (Volkmann et al. 2023). Scleroderma is a long- term condition for which there is no cure. It is associated with life- threatening condi­tions and has a high mortality rate (Tate et al.2019). Scleroderma occurs due to an overproduction of collagen that is deposited in the skin, blood vessels and internal organs, resulting in scarring and brosis in aected areas (Rayner etal.2009). Immune dysfunction and microvascular abnormalities are also common features (Tate etal.2019).
124 ATYPICAL CAUSES OF LEG ULCERATION
https://t.me/medicina_free
There are two main clinical forms of systemic scleroderma – diuse, which primarily aects the upper arms, thighs and trunk; and limited, which involves the lower arms and legs (Rayner etal.2009).
History
Patients with scleroderma may present with a known history of systemic scleroderma, thus making the association with leg ulceration and a subsequent diagnosis of the underlying aetiology a more obvious consideration for the assessing clinician. Scleroderma can be dicult to diagnose, particularly in the earlier stages of the disease, so patients may present with cutaneous symptoms and wounds before a formal diagnosis of the disease has been made (Volkmann et al. 2023). Skin changes become more apparent as the disease progresses over time, with skin thickening of the ngers being the primary diagnostic criterion. Patients may present with overlapping symptoms of other autoimmune diseases, such as RA and Sjögren syndrome, which can co- exist with systemic scleroderma (Volkmann etal.2023). Positive family history is also the strongest identied risk factor for systemic scleroderma (Arnett etal.2001).
Raynaud’s phenomenon is commonly associated with scleroderma and is often the rst reported symptom along with swelling and inammation of the hands and feet (Volkmann etal.2023). Patients may present with the typical symptoms of Raynaud’s: pain, numbness, white skin and pins and needles to the ngers and toes caused by reduced blood ow from vasoconstriction. Raynaud’s may be quite severe when it occurs alongside scleroderma, with ulceration occurring to the digits in up to 50% of cases (Khimdas etal.2011).
Patients may report some diculties with swallowing because of scleroderma and consequently have a reduced nutritional intake, which can aect wound healing (Tate etal.2019). Malnutrition, par­ticularly protein deciency, adversely aects the formation of new blood vessels and the synthesis of collagen, which are essential for rebuilding the extracellular matrix during the proliferative phase of wound healing (Ghaly etal.2021). Micronutrients (e.g. amino acids) and key vitamins also play important roles in the inammatory phase for collagen synthesis. Wound healing requires signicant amounts of energy that would normally be provided by the body’s natural
Atypical Causes of Leg Ulceration 125
https://t.me/medicina_free
energy stores, but these are signicantly depleted when nutritional intake is poor (Ghaly etal.2021).
Examination
Known skin- related symptoms of systemic sclerosis are thickened skin, nger ulcerations, joint contractures, skin pigmentation changes and itching (Hudson etal.2009; Tate etal. 2019). Patients may also present with dry, scaly skin (Figure3.5).
Calcium deposits may be visible or palpable within the wound bed (Figure3.6)– calcinosis cutis, a deposition of insoluble calcium salts in the skin and/or subcutaneous tissues that can occur in damaged, inamed, neoplastic or necrotic skin (Ngan2005), is a common feature with systemic sclerosis (Tate et al.2019), and ulceration can occur secondary to the calcinosis in some places. Calcium deposits can contribute to a prolonged inammatory response within the wound as they are perceived as a foreign body; thus they can delay healing and increase the risk of infection. They can also cause pain and strongly adhere to the wound bed, making removal dicult.
Ulcers related to scleroderma are often very painful due to the ischaemia caused by Raynaud’s, and in more severe cases gangrene may be evident.
FIGURE3.5 Ulceration associated with systemic scleroderma with visible
skin brosis. Source: Used with permission from Cardi & Vale University Health Board.
126 ATYPICAL CAUSES OF LEG ULCERATION
https://t.me/medicina_free
FIGURE3.6 Calcium deposits in the wound bed related to calcinosis cutis
and scleroderma. Source: Chave etal. (2001) / John Wiley & Sons. Reproduced with permission.
Investigation
If systemic scleroderma is suspected but not yet diagnosed, blood tests to detect the presence of specic autoantibodies can aid in the diagnostic process, as can skin biopsy. The involvement of the heart, lungs, kidneys and gastrointestinal system would also need to be assessed (Tate etal.2019). Referral to a specialist team for diagnosis and management of both scleroderma and any associated ulceration is recommended (Tate etal.2019).
Vascular assessment is advised to identify any concomitant venous and/or arterial disease in the lower limb, with appropriate onward referral to vascular for intervention as indicated. An X­may be ordered if calcinosis is present to check the extent of calcium deposition in and around the wound.
ray
Diagnosis
Diagnosis of systemic scleroderma itself is usually based on the clas­sication criteria stipulated by the American College of Rheumatol­ogy and European League Against Rheumatism collaborative
Atypical Causes of Leg Ulceration 127
https://t.me/medicina_free
(Table3.5; van den Hoogen et al.2013). Early identication is key and referral to appropriate specialists will aid in timely diagnosis and management.
Diagnosis of leg ulcers associated with scleroderma will primarily be based on the medical history and patient examination. Skin biopsy can indicate the blocking of the small vessels and the presence of inammatory mediators (Shanmugam etal.2010).
TABLE3.5 
Against Rheumatism collaborative criteria for classication of systemic sclerosis
Item Sub- item(s) Weight/score
Skin thickening of the ngers
of both hands extending proximal to the metacarpophalangeal joints
(sucient criterion)
Skin thickening of the ngers
(only count the higher score)
Fingertip lesions (only count the
higher score)
Telangiectasia — Abnormal nailfold capillaries 2 Pulmonary arterial hyperten-
sion and/or interstitial lung disease
(maximum score is 2)
Raynaud’s phenomenon 3
The American College of Rheumatology and European League
a
.
9
Puy ngers;
Sclerodactyly of the ngers (distal to the metacar­pophalangeal joints but proximal to the proximal interphalangeal
joints) Digital tip ulcers 2 Fingertip pitting scars 3
2
Pulmonary arterial
hypertension Interstitial
lung disease
2 4
2 2
b
(Continued)
128 ATYPICAL CAUSES OF LEG ULCERATION
https://t.me/medicina_free
TABLE3.5 
(Continued)
Item Sub- item(s) Weight/score
SSc- related autoantibodies
(anticentromere, anti– topoisomerase I [anti–Scl- 70], anti–RNA polymerase III)
Anticentromere Anti–topoisomerase I Anti–RNA pol-
ymerase III
3
(maximum score is 3)
a
These criteria are applicable to any patient considered for inclusion in a systemic sclerosis study. The criteria are not applicable to patients with skin thickening sparing the ngers or to patients who have a scleroderma- like disorder that better explains that manifestation (e.g. nephrogenic sclerosing brosis, generalised morphea, eosinophilic fasciitis, scleredema diabeticorum, scleromyxedema, erythromyalgia, porphyria, lichen sclerosis, graft- versus- host disease, diabetic cheiroarthrophy).
b
The total score is determined by adding the maximum weight (score) in each category. Patients with a total score of 9 are classied as having denite systemic sclerosis. SSc, systemic sclerosis. Source: van den Hoogen etal. (2013) / BMJ Publishing Group. Reproduced by permission.
Implementation
Pharmacological management of systemic scleroderma usually involves some form of immunosuppressant agent, such as rituximab or cyclophosphamide, which can exert anti- inammatory and/or anti- brotic properties to manage the underlying brosis and vasculopathy at a cellular level (Volkmann etal.2023).
As well as the potential for these types of drugs to aect the wound healing process, they can diminish the immune response to the extent that there is a higher risk of opportunistic infection, particularly if malnutrition is also involved (Volkmann etal.2023). Calcinosis in the wound bed also increases the risk of infection. Overt and covert signs of local and spreading wound infection should be closely observed and treated appropriately (see Chapter5). Patients should also undergo regular nutritional screening using validated tools as per local policy, and a referral made to a dietician for nutritional support as recommended by local pathways.
b
Atypical Causes of Leg Ulceration 129
https://t.me/medicina_free
Treatment of leg ulcers related to scleroderma focuses on the management of symptoms and prevention of deterioration. Pain management is an important part of symptom control due to the severe pain that can be experienced both from the scleroderma generally and from the scleroderma- related leg ulceration, which can aect the patient’s quality of life. Appropriate pain assessment should be conducted and documented and local pain management algorithms followed; referral should be made to pain management specialists as required (see Chapter6). Pain from the reduced blood ow associated with the Raynaud’s component of the disease is often treated with systemic vasodilators, such as sildenal or nifedipine, or prostacyclins (e.g. iloprost), alongside traditional analgesia such as paracetamol and NSAIDs. Other recommendations for preventing and managing Raynaud’s attacks include avoiding the cold where possible; wearing warm mittens and hand and foot warmers can be useful (Pope2022). Treating Raynaud’s phenomenon is also important from a calcinosis perspective, as underlying ischaemia is known to worsen calcinosis, which tends to form in areas of local trauma (Pope2022).
Skincare is another key component of the management of skin thickening from scleroderma and for maintaining the integrity of peri­wound skin. Patients are also prone to pruritic rashes, which can be uncomfortable and bothersome. Regular use of skin emollients to promote adequately moisturised skin is essential; joint guidelines from the British Society of Rheumatology (BSR) and British Health Professionals in Rheumatology (BHPR) recommend the use of lanolin­based moisturisers specically (Denton et al.2016). Antihistamines are useful to help reduce skin itch alongside moisturisation; other practical recommendations include limiting time in hot baths and showers and avoiding harsh soaps and fragranced moisturisers (Volkmann etal.2023).
In terms of local wound care, competent practitioners may choose to remove supercial and loose pieces of calcium where possible and as tolerated by the patient; this in essence removes the perceived foreign body to promote healing and reduce infection risk. Surgical intervention is usually only considered if the calcinosis is severe and aects the patient’s ability to function and their quality of life (Tate etal.2019). Dressing choice should be guided by the TIMES assessment of the wound environment, with consideration given to
130 ATYPICAL CAUSES OF LEG ULCERATION
https://t.me/medicina_free
minimising wound pain at dressing change and managing infection. Exudate management can be supported through the use of compression, often at a reduced dose unless accompanied by signicant venous disease.
Sickle Cell Disease
Sickle cell disease (SCD) is an umbrella term for various genotypes that all present with sickle- shaped blood cells. It is an inherited haematological disorder where a mutation in the b globin genes in the bone marrow produces red blood cells with defective haemoglobin HbS. Where both parents carry the gene there is a one in four chance of a child having the disease. The HbS produces blood dyscrasia aecting multiple organs and related systems, with sickle cell anaemia occurring when there are two abnormal HbSS genes from two parents. Variants present where genes from one parent combine with another haemoglobin variant as with thalassaemia, which reduces the concentration of haemoglobin. Sickle cell anaemia and thalassaemia variant are the most severe forms of SCD. Sickle cell trait occurs where there are genes from one parent only, resulting in the child being a carrier of the disease but asymptomatic.
The genetic presence of the disease has been linked to areas where malaria occurs, commonly in Africa and among people of African origin, but also in the Caribbean, South and Central America, the Eastern Mediterranean and Asia. The highest prevalence is found in populations from sub- Saharan Africa. In the United Kingdom SCD aects 15 000 people with almost 300 babies born each year. Children with SCD are at an increased risk of stroke, the highest risk being between 2 and 16 years of age (www.sicklecellsociety.org). The median UK survival is 66/67 years (DeBaun et al.2019; Gardner etal.2016).
History
The sickle shape is caused by long rigid polymer chains forming within the red blood cell once it has become deoxygenated. This distinguishes it from normal red blood cells and has multiple eects. The sickle cell has a shorter lifespan (normal 90–120days; sickle 10–20days) and is less able to travel through the circulation due to its
Atypical Causes of Leg Ulceration 131
https://t.me/medicina_free
shape. It is dehydrated, rigid and sticky with a weakened cell membrane, which along with its shape makes it vulnerable to adhesion and aggregation. As a result, it is easily trapped in smaller vessels leading to impaired blood ow preventing oxygen delivery to the tissues, ischaemia and tissue death. This produces an acute crisis with chronic damage. Narrowing and occlusion of larger vessels produce chronic sheer damage and adherence of red blood cells to the endothelium alongside vasoconstriction and nitric oxide deciency. This leads to pulmonary hypertension and stroke.
Examination
The severity of the disease varies from mild to severe, including being life limiting. Dierent areas of the body may be aected, and the consequences include lung and cardiopulmonary disease, central nervous system complications including infarcts, retinopathy and blindness, renal disease and hip necrosis. Symptoms therefore vary between individuals, with chronic anaemia and severe intermittent pain being the most common clinical manifestations. Chronic daily pain has been found to increase with age, aecting 30–40% of adults and adolescents (Brandow and Liem2022). Painful acute episodes are triggered by the inammatory process and when the red blood cell changes shape after oxygen has been released. A sickle cell crisis is severely painful and occurs in one isolated site or multiple locations including pelvis, ribs, spine and sternum. Chronic pain develops with the sensitisation of the central and/or peripheral nervous system. It may be diuse and have neuropathic elements (see Chapter7).
Sickle cell leg ulceration is one of the clinical presentations of this disease and is associated with low haemoglobin concentrations combined with a high rate of intravascular haemolysis (Koshy etal.1989). Minniti and Kato (2016) imaged, measured and examined the eect of SCD and found that ulcerated sites contained a high blood ow with evidence of chronic inammation, cutaneous vasodilation, venostasis and thrombosis, and that leg ulcers were an end-
organ complication.
Minniti and Kato (2016) outline three dierent presentations of ulceration: the one- time ulcer, the stuttering ulcer that comes and goes, and the chronic recurrent disabling ulcer. Common sites of
Соседние файлы в папке @xirurgi_2025